No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. 1998

R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
Department of Medical Genetics, University of Cambridge, Addenbrooke's Hospital, United Kingdom.

Tryptophan hydroxylase (TPH) is the rate-limiting enzyme in the synthesis of 5-hydroxytryptamine (5-HT). An association study in bipolar affective disorder I or unipolar major affective disorder was performed by using a Bfa I restriction site polymorphism within intron 7 of the tryptophan hydroxylase gene. A total of 118 bipolar, 125 unipolar, and 437 control subjects were used in the study (1:3.7 bipolar:control, 1:3.5 unipolar:control). There were no significant differences in TPH allele or genotype frequencies between the affective disorder and control groups. In addition, bipolar and/or unipolar subjects with or without a history of suicide attempts were compared for the TPH polymorphism. No significant differences were found between suicidal and non-suicidal groups in major affective disorder, in contrast to a previous study suggesting an association of this polymorphism with a history of suicide attempts among alcoholic violent offenders.

UI MeSH Term Description Entries
D007438 Introns Sequences of DNA in the genes that are located between the EXONS. They are transcribed along with the exons but are removed from the primary gene transcript by RNA SPLICING to leave mature RNA. Some introns code for separate genes. Intervening Sequences,Sequences, Intervening,Intervening Sequence,Intron,Sequence, Intervening
D008297 Male Males
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D005260 Female Females
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D013406 Suicide, Attempted The unsuccessful attempt to kill oneself. Parasuicide,Suicide Attempt,Attempt, Suicide,Attempted Suicide,Parasuicides
D014365 Tryptophan Hydroxylase An enzyme that catalyzes the hydroxylation of TRYPTOPHAN to 5-HYDROXYTRYPTOPHAN in the presence of NADPH and molecular oxygen. It is important in the biosynthesis of SEROTONIN. Tryptophan Monooxygenase,Hydroxylase, Tryptophan,Monooxygenase, Tryptophan
D019964 Mood Disorders Those disorders that have a disturbance in mood as their predominant feature. Affective Disorders,Affective Disorder,Disorder, Affective,Disorder, Mood,Disorders, Affective,Disorders, Mood,Mood Disorder

Related Publications

R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
January 1999, Archives of general psychiatry,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
April 2010, Journal of psychiatric research,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
November 1998, Acta psychiatrica Scandinavica,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
March 2001, Biological psychiatry,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
January 2005, Neuropsychobiology,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
June 2000, American journal of medical genetics,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
March 2005, BMC medical genetics,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
April 1993, Journal of medical genetics,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
May 1995, Journal of affective disorders,
R A Furlong, and L Ho, and J S Rubinsztein, and C Walsh, and E S Paykel, and D C Rubinsztein
June 2009, Psychiatric genetics,
Copied contents to your clipboard!